secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2022-09-27T23:59:59+00:00
Accession:  0001104659-22-103164
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics CFO Anthony Kim to depart Sept 30 as part of capital conservation measures
--------------------------------------------------------------------------------

- CFO Anthony Kim separated effective September 30, 2022; part of company's capital conservation measures.
- Severance benefits provided consistent with his Employment Agreement upon signing release.
- No successor named; CEO Peter Hoang remains.
- Company implementing cost-saving measures; CFO exit follows prior cost reduction steps.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465922103164/0001104659-22-103164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465922103164/tm2226666d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-103164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer